Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Bacterial Infections and Mycoses

  Free Subscription


28.03.2022

1 Am J Med
1 Am J Respir Crit Care Med
1 Am J Trop Med Hyg
44 Antimicrob Agents Chemother
2 BMC Neurol
2 Clin Infect Dis
2 Curr Microbiol
4 Diagn Microbiol Infect Dis
1 Drugs
6 Eur J Clin Microbiol Infect Dis
1 Infect Immun
2 J Antimicrob Chemother
1 J Bacteriol
1 J Biol Chem
1 J Clin Microbiol
2 J Immunol
1 J Infect Dis
2 Lancet
2 MMWR Morb Mortal Wkly Rep
3 N Engl J Med
1 PLoS Negl Trop Dis
4 PLoS One
2 PLoS Pathog
2 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Med

  1. ADAMS J, Elton-Marshall T, Shojaei E, Silverman M, et al
    Peripherally Inserted Central Catheter Line Misuse Among Persons Who Inject Drugs while on Therapy for Infective Endocarditis is Associated with Infective Endocarditis Recurrence and Death.
    Am J Med. 2022 Mar 15. pii: S0002-9343(22)00172.
    PubMed         Abstract available


    Am J Respir Crit Care Med

  2. LANGE C, Barry Iii CE, Horsburgh CR Jr
    Treatments of Multidrug-Resistant Tuberculosis: Light at the End of the Tunnel.
    Am J Respir Crit Care Med. 2022 Mar 23. doi: 10.1164/rccm.202202-0393.
    PubMed        


    Am J Trop Med Hyg

  3. PARAJULI N, Shrestha S
    Facial Tuberculoid Leprosy.
    Am J Trop Med Hyg. 2022 Mar 21. pii: tpmd210696. doi: 10.4269/ajtmh.21-0696.
    PubMed        


    Antimicrob Agents Chemother

  4. EVERT BJ, Slesarenko VA, Punnasseril JMJ, Taha, et al
    Self-inhibitory peptides targeting the Neisseria gonorrhoeae MtrCDE efflux pump increase antibiotic susceptibility.
    Antimicrob Agents Chemother. 2021 Oct 11:AAC0154221. doi: 10.1128/AAC.01542.
    PubMed         Abstract available

  5. BONNET PL, Le Gal S, Hoffmann CV, Morio F, et al
    Highly Conserved gsc1 Gene of Pneumocystis jirovecii in Patients with or without Prior Exposure to Echinocandins.
    Antimicrob Agents Chemother. 2022;66:e0156321.
    PubMed         Abstract available

  6. ARAGAW WW, Roubert C, Fontaine E, Lagrange S, et al
    Cyclohexyl-griselimycin Is Active against Mycobacterium abscessus in Mice.
    Antimicrob Agents Chemother. 2022;66:e0140021.
    PubMed         Abstract available

  7. LIAO YS, Chen BH, Teng RH, Wang YW, et al
    Antimicrobial resistance in Campylobacter coli and Campylobacter jejuni from human campylobacteriosis in Taiwan, 2016-2019.
    Antimicrob Agents Chemother. 2021 Nov 8:AAC0173621. doi: 10.1128/AAC.01736.
    PubMed         Abstract available

  8. MCCONVILLE TH, Austin ED, Geng W, Shi Q, et al
    In Vitro Cytotoxicity and Clinical Correlates of MRSA Bacteremia.
    Antimicrob Agents Chemother. 2022;66:e0155921.
    PubMed         Abstract available

  9. WULLNER D, Gesper M, Haupt A, Liang X, et al
    Adaptive Responses of Pseudomonas aeruginosa to Treatment with Antibiotics.
    Antimicrob Agents Chemother. 2022;66:e0087821.
    PubMed         Abstract available

  10. PHAN JR, Do DM, Truong MC, Ngo C, et al
    An Aniline-Substituted Bile Salt Analog Protects both Mice and Hamsters from Multiple Clostridioides difficile Strains.
    Antimicrob Agents Chemother. 2022;66:e0143521.
    PubMed         Abstract available

  11. PHAN MD, Peters KM, Alvarez Fraga L, Wallis SC, et al
    Plasmid-mediated ciprofloxacin resistance imparts a selective advantage on Escherichia coli ST131.
    Antimicrob Agents Chemother. 2021 Nov 15:AAC0214621. doi: 10.1128/AAC.02146.
    PubMed         Abstract available

  12. CRANE SD, Banerjee SK, Pechous RD
    Treatment with Fluticasone Propionate Increases Antibiotic Efficacy during Treatment of Late-Stage Primary Pneumonic Plague.
    Antimicrob Agents Chemother. 2022;66:e0127521.
    PubMed         Abstract available

  13. RIVAS L, Alcalde-Rico M, Martinez JR, Moreno V, et al
    Real-world Performance of Susceptibility Testing for Ceftolozane/Tazobactam Against Non-Carbapenemase-Producing Carbapenem-Resistant Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2021 Nov 15:AAC0165721. doi: 10.1128/AAC.01657.
    PubMed         Abstract available

  14. ZHENG H, Wang Y, He W, Li F, et al
    In Vitro Activity of Pretomanid against Nontuberculous Mycobacteria.
    Antimicrob Agents Chemother. 2022;66:e0181021.
    PubMed        

  15. YU R, Chen Z, Schwarz S, Yao H, et al
    Mobilization of tet(X4) by IS1 Family Elements in Porcine Escherichia coli Isolates.
    Antimicrob Agents Chemother. 2022;66:e0159721.
    PubMed         Abstract available

  16. SINDELDECKER D, Prakash S, Stoodley P
    Exploration of the Pharmacodynamics for Pseudomonas aeruginosa Biofilm Eradication by Tobramycin.
    Antimicrob Agents Chemother. 2022;66:e0137121.
    PubMed         Abstract available

  17. D'AMICO H, Wallace KL, Burgess D, Burgess DS, et al
    Acute Kidney Injury Associated with Area under the Curve versus Trough Monitoring of Vancomycin in Obese Patients.
    Antimicrob Agents Chemother. 2022;66:e0088621.
    PubMed         Abstract available

  18. AMBATI S, Pham T, Lewis ZA, Lin X, et al
    DectiSomes: Glycan Targeting of Liposomal Drugs Improves the Treatment of Disseminated Candidiasis.
    Antimicrob Agents Chemother. 2022;66:e0146721.
    PubMed         Abstract available

  19. SCHILDKRAUT JA, Coolen JPM, Burbaud S, Sangen JJN, et al
    RNA Sequencing Elucidates Drug-Specific Mechanisms of Antibiotic Tolerance and Resistance in Mycobacterium abscessus.
    Antimicrob Agents Chemother. 2022;66:e0150921.
    PubMed         Abstract available

  20. WARRYN L, Pluschke G
    Efficacy of an Acid-Oxidizing Solution against Mycobacterium ulcerans.
    Antimicrob Agents Chemother. 2022;66:e0087021.
    PubMed         Abstract available

  21. NICKLAS DA, Maggioncalda EC, Story-Roller E, Eichelman B, et al
    Potency of Omadacycline against Mycobacteroides abscessus Clinical Isolates In Vitro and in a Mouse Model of Pulmonary Infection.
    Antimicrob Agents Chemother. 2022;66:e0170421.
    PubMed         Abstract available

  22. RAO S, Betancourt-Garcia M, Kare-Opaneye YO, Swierczewski BE, et al
    Critically Ill Patient with Multidrug-Resistant Acinetobacter baumannii Respiratory Infection Successfully Treated with Intravenous and Nebulized Bacteriophage Therapy.
    Antimicrob Agents Chemother. 2022;66:e0082421.
    PubMed         Abstract available

  23. ONG V, Wills S, Watson D, Sandison T, et al
    Metabolism, Excretion, and Mass Balance of [(14)C]-Rezafungin in Animals and Humans.
    Antimicrob Agents Chemother. 2022;66:e0139021.
    PubMed         Abstract available

  24. MISHRA NN, Lew C, Abdelhady W, Lapitan CK, et al
    Synergy Mechanisms of Daptomycin-Fosfomycin Combinations in Daptomycin-Susceptible and -Resistant Methicillin-Resistant S. aureus: In vitro, Ex vivo and In vivo Metrics.
    Antimicrob Agents Chemother. 2021 Oct 25:AAC0164921. doi: 10.1128/AAC.01649.
    PubMed         Abstract available

  25. EALES BM, Tam VH
    Case Commentary: Novel Therapy for Multidrug-Resistant Acinetobacter baumannii Infection.
    Antimicrob Agents Chemother. 2022;66:e0199621.
    PubMed         Abstract available

  26. LEE YL, Ko WC, Hsueh PR
    Geographic Patterns of Carbapenem-resistant Pseudomonas aeruginosa in the Asia-Pacific Region: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2015-2019.
    Antimicrob Agents Chemother. 2021 Nov 22:AAC0200021. doi: 10.1128/AAC.02000.
    PubMed         Abstract available

  27. BAO X, Bove M, Coenye T
    Organic Acids and Their Salts Potentiate the Activity of Selected Antibiotics against Pseudomonas aeruginosa Biofilms Grown in a Synthetic Cystic Fibrosis Sputum Medium.
    Antimicrob Agents Chemother. 2022;66:e0187521.
    PubMed         Abstract available

  28. APPANEAL HJ, Lopes VV, LaPlante KL, Caffrey AR, et al
    Treatment, Clinical Outcomes, and Predictors of Mortality among a National Cohort of Admitted Patients with Acinetobacter baumannii Infection.
    Antimicrob Agents Chemother. 2022;66:e0197521.
    PubMed         Abstract available

  29. KURBATFINSKI N, Goodman SD, Bakaletz LO
    A Humanized Monoclonal Antibody Potentiates Killing of Diverse Biofilm-Forming Respiratory Tract Pathogens by Antibiotics.
    Antimicrob Agents Chemother. 2022;66:e0187721.
    PubMed         Abstract available

  30. BUTLER MS, Gigante V, Sati H, Paulin S, et al
    Analysis of the Clinical Pipeline of Treatments for Drug-Resistant Bacterial Infections: Despite Progress, More Action Is Needed.
    Antimicrob Agents Chemother. 2022;66:e0199121.
    PubMed         Abstract available

  31. BLASCO L, Bleriot I, Gonzalez de Aledo M, Fernandez-Garcia L, et al
    Development of an Anti-Acinetobacter baumannii Biofilm Phage Cocktail: Genomic Adaptation to the Host.
    Antimicrob Agents Chemother. 2022;66:e0192321.
    PubMed         Abstract available

  32. BILAL H, Tait JR, Lang Y, Zhou J, et al
    Simulated Intravenous versus Inhaled Tobramycin with or without Intravenous Ceftazidime Evaluated against Hypermutable Pseudomonas aeruginosa via a Dynamic Biofilm Model and Mechanism-Based Modeling.
    Antimicrob Agents Chemother. 2022;66:e0220321.
    PubMed         Abstract available

  33. DIDE-AGOSSOU C, Bauman AA, Ramey ME, Rossmassler K, et al
    Combination of Mycobacterium tuberculosis RS Ratio and CFU Improves the Ability of Murine Efficacy Experiments to Distinguish between Drug Treatments.
    Antimicrob Agents Chemother. 2022 Mar 21:e0231021. doi: 10.1128/aac.02310.
    PubMed         Abstract available

  34. JI X, Kruger H, Wang Y, Fessler AT, et al
    Tn560, a Novel Tn554 Family Transposon from Porcine Methicillin-Resistant Staphylococcus aureus ST398, Carries a Multiresistance Gene Cluster Comprising a Novel spc Gene Variant and the Genes lsa(E) and lnu(B).
    Antimicrob Agents Chemother. 2022 Mar 22:e0194721. doi: 10.1128/aac.01947.
    PubMed        

  35. TASNEEN R, Garcia A, Converse PJ, Zimmerman MD, et al
    Novel Regimens of Bedaquiline-Pyrazinamide Combined with Moxifloxacin, Rifabutin, Delamanid and/or OPC-167832 in Murine Tuberculosis Models.
    Antimicrob Agents Chemother. 2022 Mar 22:e0239821. doi: 10.1128/aac.02398.
    PubMed         Abstract available

  36. BIZOT E, Cointe A, Bidet P, Mariani-Kurkdjian P, et al
    Azithromycin Resistance in Shiga Toxin-Producing Escherichia coli in France between 2004 and 2020 and Detection of mef(C)-mph(G) Genes.
    Antimicrob Agents Chemother. 2022;66:e0194921.
    PubMed         Abstract available

  37. LONG H, Hu Y, Feng Y, Zong Z, et al
    Genome analysis of Klebsiella oxytoca complex for antimicrobial resistance and virulence genes.
    Antimicrob Agents Chemother. 2022 Jan 10:aac0218321. doi: 10.1128/aac.02183.
    PubMed         Abstract available

  38. LI Y, Zhang L, Xiu L, Wang D, et al
    A Multiplex Molecular Assay for Detection of Six penA Codons To Predict Decreased Susceptibility to Cephalosporins in Neisseria gonorrhoeae.
    Antimicrob Agents Chemother. 2022;66:e0170921.
    PubMed         Abstract available

  39. SAWATZKY P, Demczuk W, Lefebvre B, Allen V, et al
    Increasing Azithromycin Resistance in Neisseria gonorrhoeae Due to NG-MAST 12302 Clonal Spread in Canada, 2015 to 2018.
    Antimicrob Agents Chemother. 2022;66:e0168821.
    PubMed         Abstract available

  40. LEE JH, Park YE, Chong YP, Shim TS, et al
    Efficacy of Fluoroquinolones as Substitutes for Ethambutol or Rifampin in the Treatment of Mycobacterium avium Complex Pulmonary Disease According to Radiologic Types.
    Antimicrob Agents Chemother. 2022;66:e0152221.
    PubMed         Abstract available

  41. RUEDAS-LOPEZ A, Alonso-Garcia I, Lasarte-Monterrubio C, Guijarro-Sanchez P, et al
    Selection of AmpC beta-Lactamase Variants and Metallo-beta-Lactamases Leading to Ceftolozane/Tazobactam and Ceftazidime/Avibactam Resistance during Treatment of MDR/XDR Pseudomonas aeruginosa Infections.
    Antimicrob Agents Chemother. 2022;66:e0206721.
    PubMed         Abstract available

  42. SELCHOW P, Ordway DJ, Verma D, Whittel N, et al
    Apramycin Overcomes the Inherent Lack of Antimicrobial Bactericidal Activity in Mycobacterium abscessus.
    Antimicrob Agents Chemother. 2022;66:e0151021.
    PubMed         Abstract available

  43. DAS S, Bush K
    Success and Challenges Associated with Large-Scale Collaborative Surveillance for Carbapenemase Genes in Gram-Negative Bacteria.
    Antimicrob Agents Chemother. 2022;66:e0229921.
    PubMed         Abstract available

  44. AGUIAR-ALVES F, Le HN, Tran VG, Gras E, et al
    Anti-virulence Bispecific Monoclonal Antibody Mediated Protection Against Pseudomonas aeruginosa Ventilator-Associated Pneumonia in a Rabbit Model.
    Antimicrob Agents Chemother. 2021 Dec 13:AAC0202221. doi: 10.1128/AAC.02022.
    PubMed         Abstract available

  45. TAKAMATSU A, Yaguchi T, Tagashira Y, Watanabe A, et al
    Nocardiosis in Japan: a Multicentric Retrospective Cohort Study.
    Antimicrob Agents Chemother. 2022;66:e0189021.
    PubMed         Abstract available

  46. WEI J, Tong K, Wang H, Wen Y, et al
    Intra-articular vancomycin for the prophylaxis of periprosthetic joint infection caused by methicillin-resistant S. aureus after total knee arthroplasty in a rat model: the dosage, efficacy, and safety.
    Antimicrob Agents Chemother. 2021 Nov 22:AAC0164121. doi: 10.1128/AAC.01641.
    PubMed         Abstract available

  47. CHUMBITA M, Puerta-Alcalde P, Gudiol C, Garcia-Pouton N, et al
    Impact of Empirical Antibiotic Regimens on Mortality in Neutropenic Patients with Bloodstream Infection Presenting with Septic Shock.
    Antimicrob Agents Chemother. 2022;66:e0174421.
    PubMed         Abstract available


    BMC Neurol

  48. LU Y, Zand R
    Characteristics of Lyme optic neuritis: a case report of Lyme associated bilateral optic neuritis and systematic review of the literature.
    BMC Neurol. 2022;22:113.
    PubMed         Abstract available

  49. TANNER JA, Richie MB, Cadwell CR, Eliaz A, et al
    Amyloid-beta related angiitis presenting as eosinophilic meningitis: a case report.
    BMC Neurol. 2022;22:116.
    PubMed         Abstract available


    Clin Infect Dis

  50. MCCALLUM AD, Pertinez HE, Chirambo AP, Sheha I, et al
    High intrapulmonary rifampicin and isoniazid concentrations are associated with rapid sputum bacillary clearance in patients with pulmonary tuberculosis.
    Clin Infect Dis. 2022 Mar 23. pii: 6553299. doi: 10.1093.
    PubMed         Abstract available

  51. PUOPOLO KM, Mukhopadhyay S, Hansen NI, Flannery DD, et al
    Group B Streptococcal Infection in Extremely Preterm Neonates and Neurodevelopmental Outcomes at 2 Years.
    Clin Infect Dis. 2022 Mar 22. pii: 6552249. doi: 10.1093.
    PubMed         Abstract available


    Curr Microbiol

  52. LI J, Zhang Q, Zhao J, Zhang H, et al
    Streptococcus mutans and Candida albicans Biofilm Inhibitors Produced by Lactiplantibacillus plantarum CCFM8724.
    Curr Microbiol. 2022;79:143.
    PubMed         Abstract available

  53. KWIATKOWSKI P, Masiuk H, Pruss A, Lopusiewicz L, et al
    Clonal Diversity, Antimicrobial Susceptibility and Presence of Genes Encoding Virulence Factors in Staphylococcus aureus Strains Isolated from Cut Wound Infections.
    Curr Microbiol. 2022;79:144.
    PubMed         Abstract available


    Diagn Microbiol Infect Dis

  54. ROSTAMIAN M, Kooti S, Mohammadi B, Salimi Y, et al
    A systematic review and meta-analysis of Listeria monocytogenes isolated from human and non-human sources: the antibiotic susceptibility aspect.
    Diagn Microbiol Infect Dis. 2022;102:115634.
    PubMed         Abstract available

  55. YOSHIMURA M, Tokushige C, Maruyama JI, Kawano Y, et al
    Emerging resistance to beta-lactams in Pantoea ananatis isolated from an immunocompetent patient with bacteremia.
    Diagn Microbiol Infect Dis. 2022;102:115633.
    PubMed         Abstract available

  56. PRINCE HE, Batterman HJ, Realegeno SE, Marlowe EM, et al
    Transience of interference in an immunoassay measuring serum levels of beta-D-glucan.
    Diagn Microbiol Infect Dis. 2022;102:115630.
    PubMed         Abstract available

  57. PFALLER MA, Carvalhaes CG, DeVries S, Huband MD, et al
    Elderly versus nonelderly patients with invasive fungal infections: species distribution and antifungal resistance, SENTRY antifungal surveillance program 2017-2019.
    Diagn Microbiol Infect Dis. 2022;102:115627.
    PubMed         Abstract available


    Drugs

  58. CHOU A, Welch E, Hunter A, Trautner BW, et al
    Antimicrobial Treatment Options for Difficult-to-Treat Resistant Gram-Negative Bacteria Causing Cystitis, Pyelonephritis, and Prostatitis: A Narrative Review.
    Drugs. 2022;82:407-438.
    PubMed         Abstract available


    Eur J Clin Microbiol Infect Dis

  59. ANDRY F, Le Marechal M, Pierre I, Recule C, et al
    Epidemiology and outcome of occult bacteremia in patients discharged from emergency departments or ambulatory units: one-year study.
    Eur J Clin Microbiol Infect Dis. 2022;41:649-655.
    PubMed         Abstract available

  60. HWEE SE, Htet NH, Naing C, Tung WS, et al
    Rapid diagnostic test (Leptocheck-WB) for detection of acute leptospirosis: a meta-analysis of diagnostic accuracy.
    Eur J Clin Microbiol Infect Dis. 2022;41:631-640.
    PubMed         Abstract available

  61. LAUPLAND KB, Stewart AG, Edwards F, Harris P, et al
    Pasteurella species bloodstream infections in Queensland, Australia, 2000-2019.
    Eur J Clin Microbiol Infect Dis. 2022;41:609-614.
    PubMed         Abstract available

  62. JOYNER G, Mavin S, Milner R, Lim C, et al
    Introduction of IgM testing for the diagnosis of acute Lyme borreliosis: a study of the benefits, limitations and costs.
    Eur J Clin Microbiol Infect Dis. 2022;41:671-675.
    PubMed         Abstract available

  63. KUTLU M, Sayin-Kutlu S, Alp-Cavus S, Ozturk SB, et al
    Mortality-associated factors of candidemia: a multi-center prospective cohort in Turkey.
    Eur J Clin Microbiol Infect Dis. 2022;41:597-607.
    PubMed         Abstract available

  64. BEAURUELLE C, Plouzeau C, Grillon A, Isnard C, et al
    Capnocytophaga zoonotic infections: a 10-year retrospective study (the French CANCAN study).
    Eur J Clin Microbiol Infect Dis. 2022;41:581-588.
    PubMed         Abstract available


    Infect Immun

  65. MADDEN K, Liang YC, Rajabalee N, Alvarez GG, et al
    Surveying the Epigenetic Landscape of Tuberculosis in Alveolar Macrophages.
    Infect Immun. 2022 Mar 21:e0052221. doi: 10.1128/iai.00522.
    PubMed         Abstract available


    J Antimicrob Chemother

  66. GEORGIOU PC, Arendrup MC, Meletiadis J
    Early phenotypic detection of fluconazole- and anidulafungin-resistant Candida glabrata isolates.
    J Antimicrob Chemother. 2022 Mar 22. pii: 6551886. doi: 10.1093.
    PubMed         Abstract available

  67. LIANG J, Macesic N, Blakeway L
    Comment on: Genetically related micafungin-resistant Candida parapsilosis blood isolates harbouring novel mutation R658G in hotspot 1 of Fks1p: a new challenge?
    J Antimicrob Chemother. 2022 Mar 24. pii: 6553323. doi: 10.1093.
    PubMed        


    J Bacteriol

  68. LIM ZL, Drever K, Dhar N, Cole ST, et al
    Mycobacterium tuberculosis EspK Has Active but Distinct Roles in the Secretion of EsxA and EspB.
    J Bacteriol. 2022 Mar 22:e0006022. doi: 10.1128/jb.00060.
    PubMed         Abstract available


    J Biol Chem

  69. JURKOWITZ MS, Azad AK, Monsma PC, Keiser TL, et al
    Mycobacterium tuberculosis encodes a YhhN family membrane protein with lysoplasmalogenase activity that protects against toxic host lysolipids.
    J Biol Chem. 2022 Mar 18:101849. doi: 10.1016/j.jbc.2022.101849.
    PubMed         Abstract available


    J Clin Microbiol

  70. GIACOBBE DR, Prattes J, Wauters J, Dettori S, et al
    Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients: a Post Hoc Analysis from the European Confederation of Medical Mycology (ECMM) COVID-19-Associated Pu
    J Clin Microbiol. 2022 Mar 24:e0229821. doi: 10.1128/jcm.02298.
    PubMed         Abstract available


    J Immunol

  71. VIKLUND M, Fredriksson J, Holdfeldt A, Lind S, et al
    Structural Determinants in the Staphylococcus aureus-Derived Phenol-Soluble Modulin alpha2 Peptide Required for Neutrophil Formyl Peptide Receptor Activation.
    J Immunol. 2022 Mar 23. pii: jimmunol.2101039. doi: 10.4049/jimmunol.2101039.
    PubMed         Abstract available

  72. GOLDMANN O, Sauerwein T, Molinari G, Rohde M, et al
    Cytosolic Sensing of Intracellular Staphylococcus aureus by Mast Cells Elicits a Type I IFN Response That Enhances Cell-Autonomous Immunity.
    J Immunol. 2022 Mar 23. pii: jimmunol.2100622. doi: 10.4049/jimmunol.2100622.
    PubMed         Abstract available


    J Infect Dis

  73. ITSKO M, Topaz N, Ousmane S, Popoola M, et al
    Enhancing meningococcal genomic surveillance in the meningitis belt using high-resolution culture-free whole genome sequencing.
    J Infect Dis. 2022 Mar 24. pii: 6553907. doi: 10.1093.
    PubMed         Abstract available


    Lancet

  74. YAKOVENKO V, Brauner R, Votinov E, Goldfarb Y, et al
    Infective endocarditis and thromboses due to antiphospholipid syndrome following acute Q fever.
    Lancet. 2022;399:1154.
    PubMed        

  75. DHEDA K, Pinto L, Mutsvangwa J, Leung CC, et al
    Accelerate investment and action to find the missing patients with tuberculosis.
    Lancet. 2022 Mar 22. pii: S0140-6736(22)00535.
    PubMed        


    MMWR Morb Mortal Wkly Rep

  76. FILARDO TD, Feng PJ, Pratt RH, Price SF, et al
    Tuberculosis - United States, 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:441-446.
    PubMed         Abstract available

  77. KANU FA, Yusuf N, Kassogue M, Ahmed B, et al
    Progress Toward Achieving and Sustaining Maternal and Neonatal Tetanus Elimination - Worldwide, 2000-2020.
    MMWR Morb Mortal Wkly Rep. 2022;71:406-411.
    PubMed         Abstract available


    N Engl J Med

  78. ONATE-OCANA LF, Perez-Diaz L
    Intestinal Tuberculosis.
    N Engl J Med. 2022 Mar 26. doi: 10.1056/NEJMicm2114345.
    PubMed        

  79. MOOSA MS, Lessells RJ
    Toward Simpler, Safer Treatment of Cryptococcal Meningitis.
    N Engl J Med. 2022;386:1179-1181.
    PubMed        

  80. JARVIS JN, Lawrence DS, Meya DB, Kagimu E, et al
    Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.
    N Engl J Med. 2022;386:1109-1120.
    PubMed         Abstract available


    PLoS Negl Trop Dis

  81. ALI O, Mengiste A, Semrau M, Tesfaye A, et al
    The impact of podoconiosis, lymphatic filariasis, and leprosy on disability and mental well-being: A systematic review.
    PLoS Negl Trop Dis. 2021;15:e0009492.
    PubMed         Abstract available


    PLoS One

  82. SAGE MAG, Cranmer KD, Semeraro ML, Ma S, et al
    A Factor H-Fc fusion protein increases complement-mediated opsonophagocytosis and killing of community associated methicillin-resistant Staphylococcus aureus.
    PLoS One. 2022;17:e0265774.
    PubMed         Abstract available

  83. BROOKS MB, Millones AK, Puma D, Contreras C, et al
    Mapping local hot spots with routine tuberculosis data: A pragmatic approach to identify spatial variability.
    PLoS One. 2022;17:e0265826.
    PubMed         Abstract available

  84. MAYA TG, Komba EV, Mensah GI, Mbelele PM, et al
    Drug susceptibility profiles and factors associated with non-tuberculous mycobacteria species circulating among patients diagnosed with pulmonary tuberculosis in Tanzania.
    PLoS One. 2022;17:e0265358.
    PubMed         Abstract available

  85. GHAFFAR N, Javad S, Farrukh MA, Shah AA, et al
    Metal nanoparticles assisted revival of Streptomycin against MDRS Staphylococcus aureus.
    PLoS One. 2022;17:e0264588.
    PubMed         Abstract available


    PLoS Pathog

  86. ROSAS MEJIA O, Gloag ES, Li J, Ruane-Foster M, et al
    Mice infected with Mycobacterium tuberculosis are resistant to acute disease caused by secondary infection with SARS-CoV-2.
    PLoS Pathog. 2022;18:e1010093.
    PubMed         Abstract available

  87. MANZER HS, Villarreal RI, Doran KS
    Targeting the BspC-vimentin interaction to develop anti-virulence therapies during Group B streptococcal meningitis.
    PLoS Pathog. 2022;18:e1010397.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  88. CHEN J, Byun H, Liu R, Jung IJ, et al
    A commensal-encoded genotoxin drives restriction of Vibrio cholerae colonization and host gut microbiome remodeling.
    Proc Natl Acad Sci U S A. 2022;119:e2121180119.
    PubMed         Abstract available

  89. KRISHNAN M, Choi J, Jang A, Choi S, et al
    Molecular mechanism underlying the TLR4 antagonistic and antiseptic activities of papiliocin, an insect innate immune response molecule.
    Proc Natl Acad Sci U S A. 2022;119:e2115669119.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bacterial Infections and Mycoses is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: